Researchers are pressing the U.S. Drug Enforcement Administration to allow them to grow marijuana for research purposes.
The researchers, who claim a recent DEA administrative law judge's ruling that it would be in "the public interest" to allow marijuana to be grown for study vindicates their cause, said samples of the plant grown by the government are difficult to obtain and of poor quality, The Washington Post reported Thursday.
"The DEA has an opportunity here to live up to its rhetoric, which has been that marijuana advocates should work on conducting research rather than filing lawsuits," said Richard Doblin, president of the Multidisciplinary Association for Psychedelic Studies, which has been fighting to test possible medical uses of marijuana for years.
"It's become more and more obvious that the DEA has been obstructing potentially beneficial medical research, and now is the time for them to change," he told the Post.
Copyright 2007 by United Press International
Related stories:
Doctors boosting marijuana dosages
Canadian health officials say doctors are increasing the dosages of medical marijuana they prescribe for patients.
Opium and marijuana research go underground
The world’s leading expert on the opium poppy has joined forces with researchers working on another infamous drug-producing plant – cannabis – in hopes of finding new uses for the much-maligned sources of heroin and marijuana.
Scientists seek marijuana's isotopic fingerprint
Scientists at the Alaska Stable Isotope Facility can tell whether marijuana confiscated in a traffic stop in Fairbanks likely came from Mexico or the Matanuska Valley. They're also working on a way to determine whether it was grown indoors or out.
Report: US drug use shows little change in 2007
(AP) -- Cocaine and methamphetamine use among young adults declined significantly last year as supplies dried up, leading to higher prices and reduced purity, the government reports. Overall use of illicit drugs showed little change.
New research reports new method to protect brain cells from diseases like Alzheimer's
New research led by Chu Chen, PhD, Associate Professor of Neuroscience at LSU Health Sciences Center New Orleans, provides evidence that one of the only naturally occurring fatty acids in the brain that has the ability to interact with the receptors originally identified as the targets of THC (the psychoactive component of marijuana) can help to protect brain cells from neurodegenerative diseases like Alzheimer's and Parkinson's.
Medicinal marijuana effective for neuropathic pain in HIV
In a double-blind, placebo-controlled clinical trial to assess the impact of smoked medical cannabis, or marijuana, on the neuropathic pain associated with HIV, researchers at the University of California, San Diego School of Medicine found that reported pain relief was greater with cannabis than with a placebo. The study, sponsored by the University of California Center for Medical Cannabis Research (CMCR) based at UC San Diego, will be published on line, August 6 in the journal
Neuropsychopharmacology.
Black girls who use marijuana engage in riskier sex, have higher STD rate
Black girls who use marijuana are more likely to engage in risky sexual acts and contract a sexually transmitted disease, a new study finds.
Energy drinks linked to risk-taking behaviors among college students
Over the last decade, energy drinks -- such as Red Bull, Monster and Rockstar -- have become nearly ubiquitous on college campuses. The global market for these types of drinks currently exceeds $3 billion a year and new products are introduced annually.